Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 11, 2004, Pages 5627-5633

  Lappas, Martha ^a   Permezel, Michael ^a   Rice, Gregory E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROSTANE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SKELETAL MUSCLE; SUBCUTANEOUS FAT; TISSUE SPECIFICITY;

ADIPOSE TISSUE; ADULT; CYTOKINES; DIABETES, GESTATIONAL; DINOPROST; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; MUSCLE, SKELETAL; OXIDATIVE STRESS; PLACENTA; PREGNANCY;

EID: 8744224513     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032097     Document Type: Article

References (38)

1. Beischer NA, Wein P, Sheedy MT, Steifen B 1996 Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust NZ J Obstet Gynaecol 36:239-247
2. Pendegrass M, Fazioni E, DeFronzo R 1995 NIDDM and GDM: same disease, another name? Diabetes Rev 3:556-583
3. Cox NJ 1994 Maternal component in NIDDM transmission. How large an effect? Diabetes 43:166-168
4. Moller DE 2000 Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11:212-217
5. Coppack SW 2001 Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60:349-356
6. Greenberg AS, McDaniel ML 2002 Identifying the links between obesity, insulin resistance and β-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32(Suppl 3): 24-34
7. Febbraio MA, Pedersen BK 2002 Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16:1335-1347
8. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82:4196-4200
9. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B 2000 Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87:2084-2089
10. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G 2001 Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol 280:E745-E751
11. Pickup JC, Mattock MB, Chusney GD, Burt D 1997 NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292
12. Muller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H 2002 Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-á or its receptors. Diabetologia 45:805-812
13. Nobata Y, Urakaze M, Temaru R, Sato A, Nakamura N, Yamazaki K, Kishida M, Takata M, Kobayashi M 2002 α-Tocopherol inhibits IL-8 synthesis induced by thrombin and high glucose in endothelial cells. Horm Metab Res 34:49-54
14. Bruun JM, Pedersen SB, Richelsen B 2001 Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 86:1267-1273
15. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD 2001 Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 175:81-92
16. Laham N, Brennecke SP, Bendtzen K, Rice GE 1994 Tumour necrosis factor α during human pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues. Eur J Endocrinol 131: 607-614
17. Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S 1999 Regulation of tumour necrosis factor-α release from human adipose tissue in vitro. J Endocrinol 163:33-38
18. Zhang Y, Pilon G, Marette A, Baracos VE 2000 Cytokines and endotoxin induce cytokine receptors in skeletal muscle. Am J Physiol 279:E196-E205
19. Laham N, Brennecke SP, Rice GE 1997 Interleukin-8 release from human gestational tissue explants: the effects of lipopolysaccharide and cytokines. Biol Reprod 57:616-620
20. West IC 2000 Radicals and oxidative stress in diabetes. Diabet Med 17:171-180
21. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387
22. Awad JA, Roberts LJ, Burk RF, Morrow JD 1996 Isoprostanes-prostaglandin- like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage. Gastroenterol Clin North Am 25: 409-427
23. Walsh SW, Vaughan JE, Wang Y, Roberts LJ 2000 Placental isoprostane is significantly increased in preeclampsia. FASEB J 14:1289-1296
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
25. 2 and troglitazone. J Clin Endocrinol Metab 87:4667-4672
26. Bartlett MS, Kendall DG 1946 The statistical analysis of variance: heterogeneity and the logarithmic transformation. J R Stat Soc 8:128-138
27. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM 2002 TNF-α is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207-2213
28. Cseh K, Winkler G, Melczer Z, Baranyi E 2000 The role of tumour necrosis factor (TNF)-α resistance in obesity and insulin resistance. Diabetologia 43:525
29. Coughlan MT, Oliva K, Georgiou HM, Permezel JM, Rice GE 2001 Glucose-induced release of tumour necrosis factor-α from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 18:921-927
30. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kem PA 1996 The expression of TNFα by human muscle. Relationship to insulin resistance. J Clin Invest 97:1111-1116
31. Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C, Ricart W 2000 Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49:517-520
32. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I 2002 Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system. J Clin Endocrinol Metab 87:4602-4606
33. Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B 1999 Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42:117-118
34. Stouthard JM, Oude Elferink R, Sauerwein HP 1996 Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun 220: 241-245
35. Nagaraju K 2001 Immunological capabilities of skeletal muscle cells. Acta Physiol Scand 171:215-223
36. Evans JL, Goldfine ID, Maddux BA, Grodsky GM 2003 Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52:1-8
37. Coughlan MT, Vervaart PP, Permezel M, Georgiou HM, Rice GE 2004 Altered placental oxidative stress status in gestational diabetes mellitus. Placenta 25:78-84
38. Myatt L, Kossenjans W, Sahay R, Eis A, Brockman D 2000 Oxidative stress causes vascular dysfunction in the placenta. J Maternal Fetal Neonatal Med 9:79-82